Special notice, total small business set-aside, first published as sources sought
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
75N98026R00085
National Institutes of Health, National Institute of Health NIH-OD. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Awarded
$770,906.97 obligated so far on USAspending
Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities
This one was awarded in 2026
127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)
- Airlift Efficiency Commercial Solutions Opening (CSO)
Department of the Air Force, FA4452 763 Ess
Combined synopsis and solicitationNAICS 541715Scott AFB, ILFA4452-25-S-C001Closes in 482 daysFeb 26, 2028 - Federal Aviation Administration (FAA) Research And Commercial Solutions Opening (RCSO) Area Of Interest (AOI) - Complexity Of Systems And Operations
Federal Aviation Administration, 693KA8 System Operations Contracts
SolicitationNAICS 541715Washington, DC693KA8-27-T-00003Closes tomorrowNov 2 - Evaluations, Assessments, and Support Services (EASS)
National Aeronautics and Space Administration, NASA Langley Research Center
PresolicitationSmall businessNAICS 541715Hampton, VA80LARC27R0003Closes in 2 daysNov 3
Description
As published on SAM.gov.
The National Institutes of Health (NIH) intends to negotiate on a sole-source basis with the University of Illinois at Chicago (UIC) for preclinical animal research services to evaluate the therapeutic effects of soluble adenylyl cyclase (sAC) inhibition on pulmonary arterial hypertension (PAH) using an established endothelial cell-specific Cav1 knockout (EC-Cav1 KO) murine model and corresponding wild-type controls.
The Government intends to solicit from a single source pursuant to FAR 13.106-1(b)(1). UIC currently maintains the established EC-Cav1 KO mouse colony required for this study, and the model is not known to be maintained by another laboratory.
This notice of intent is not a request for competitive quotations. However, all responsible sources that believe they can satisfy the Government's requirements may submit a capability statement and/or quotation for consideration by the Government.
Please see the attached Notice of Intent to Sole Source for the complete description of the requirement, basis for the intended sole-source acquisition, response instructions, and applicable response deadline.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Attachment 1 - Sources Sought Notice - NHLBI Innovation Commercialization Ecosystem.pdf155 KB, June 4, 2026
- Notice of Intent to Sole Source_Therapeutic Role of Soluble Adenylyl Cyclase Inhibition.pdf148 KB, September 14, 2026
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Arbor Research, LLC
- UEI
- DVSNRG76MU54
- CAGE
- 99AG7
- Vendor location
- Ann Arbor, MI
- Contract
- 75N98026F00459 under 47QRAA24D00BA, delivery order
- Obligated
- $770,906.97, potential $2,997,347
- Actions
- 1 between September 29, 2026 and September 29, 2026
- Competition
- Full and Open Competition, 7 offers received
- Described as
- Nhlbi Innovation and Commercialization Ecosystem: Product Development Support and Program Evaluation
- Match
- solicitation number 75N98026R00085 equals the FPDS solicitation identifier; same sub-agency 7529 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 4, 2026
Sources sought
NHLBI Innovation and Commercialization Ecosystem: Product Development Support and Program Evaluation
Due June 18, 2026 at 4:00 PM EDT. SAM.gov, notice adfd909f33094919925b63daff11cf84
1 revisions on SAM
- June 4, 2026: publish, sources sought
September 14, 2026
Special notice
Due September 21, 2026 at 12:00 PM EDT. SAM.gov, notice 955c40f8d97c42e081a4c82c09bdb80c
1 revisions on SAM
- September 14, 2026: publish, special notice
Points of contact
- Donna Cornishdonna.cornish@nih.gov